Led by postdoctoral fellow Cassi Estrem under the guidance of Associate Professor Steven Flavell, the team sought to identify the precise molecular cues from bacteria that activate specific neurons within the worm’s alimentary canal. The neuron of focus, known as NSM, had been previously characterized for its capacity to detect ingested bacteria via acid-sensing ion channels (ASICs), which are highly conserved across species, including humans. When NSM neurons sense favorable bacteria, they release serotonin, a neurotransmitter that promotes increased feeding and reduced locomotion, thereby enhancing the worm’s ability to capitalize on available nutritious microbes.

However, a critical gap in understanding pertained to the exact bacterial components that stimulate NSM activation. The researchers embarked on a methodical dissection approach, exposing C. elegans to a diverse panel of over twenty bacterial species, all native components of its environment, and then fractionating these bacteria into molecular constituents to pinpoint the active stimulants. Remarkably, canonical biomolecules such as DNA, proteins, lipids, and monosaccharide sugars were ruled out as triggers. Instead, the team discovered that complex polysaccharide structures coating the bacterial surface were the primary ligands sensed by NSM neurons.

The detailed analyses revealed that in gram-positive bacteria, peptidoglycan—a rigid polysaccharide integral to bacterial cell walls—served as a potent activator of NSM. Gram-negative bacteria, which have a distinct outer membrane structure, appear to present alternative polysaccharides responsible for this activation, although these differ chemically from peptidoglycan. Functional experiments further demonstrated that these polysaccharide signals not only induce electrophysiological responses in NSM neurons but also evoke distinct behavioral outputs, including increased pharyngeal pumping and attenuated crawling speed, both optimizing nutrient intake.

Delving deeper, genetic manipulations that knocked out ASIC channels in NSM effectively abolished both neural response and associated behaviors, lending strong evidence that ASICs are indispensable transducers of these bacterial polysaccharide signals. This finding underscores a robust molecular mechanism by which the nematode’s nervous system discriminates beneficial microbes at a chemical level, linking environmental cues directly to behavioral paradigms.

Yet, survival in complex microbial landscapes also demands recognition of harmful bacteria. To explore the nematode’s avoidance strategies, the team studied Serratia marcescens, a bacterium with strains varying in virulence and pigmentation. The red pigment prodigiosin, toxic to C. elegans, was found to suppress NSM activation and the typical feeding behavior elicited by non-pigmented strains. When prodigiosin was artificially added to otherwise palatable bacteria, it prevented NSM response and inhibited ingestion, revealing a neuronal detection system finely tuned not only for nutrient identification but also for danger avoidance.

This dual functionality of the NSM neuron in detecting both beneficial polysaccharides and harmful bacterial metabolites illuminates a sophisticated sensory circuit embedded within the worm’s alimentary canal. Such findings have profound implications for understanding host-microbe interactions, suggesting that microbial modulation of neuronal circuits may be a conserved evolutionary feature across animal taxa.

Importantly, the conserved nature of acid-sensing ion channels and polysaccharide recognition pathways hints that similar mechanisms might operate in higher organisms, including mammals, shaping behaviors and physiological responses to gut microbiota. This opens exciting avenues for translational research, where deciphering bacterial signals could elucidate novel intervention points in human neurological disorders mediated by gut bacteria.

The study also highlights how model organisms with specialized bacterial diets, such as C. elegans, offer unparalleled insights into the molecular dialogue between microbes and the nervous system. These insights deepen our mechanistic understanding of how bacteria may influence brain function and behavior, moving beyond associative studies towards causal elucidation.

The implications extend to therapeutic strategies aiming to modulate the microbiome-neuron interface with precision, potentially enabling the development of targeted supplements or drugs that replicate or block specific bacterial chemical signals to beneficially modify human health outcomes.

With funding from prestigious institutions including the NIH, McKnight Foundation, Alfred P. Sloan Foundation, Howard Hughes Medical Institute, and The Freedom Together Foundation, this comprehensive investigation was poised to uncover chemical-neuronal pathways previously obscured in more complex animal systems.

This impressive body of work, titled “Identification of bacterial signals that modulate enteric sensory neurons to influence behavior in C. elegans,” was published in the April 2026 issue of Current Biology. It represents a milestone in microbiome research, emphasizing the concrete molecular mechanisms by which bacteria and nervous systems engage in cross-kingdom communication.

By elucidating the chemical signatures exploited by sensory neurons within the gut, this study paves the way for a new frontier in neuroscience and microbiology, where behavior can be understood as an emergent property of intricate bacterial-host dialogues shaped over evolutionary time.

Subject of Research: Interaction between bacterial chemical signals and enteric sensory neurons influencing behavior in C. elegans
Article Title: Identification of bacterial signals that modulate enteric sensory neurons to influence behavior in C. elegans
News Publication Date: 20-Apr-2026
Web References: http://dx.doi.org/10.1016/j.cub.2026.03.070
Image Credits: Cassi Estrem/MIT Picower Institute
Keywords: Neuroscience, Microbiome, Gut Microbiota, Bacteria, Sensory Neurons, Acid-Sensing Ion Channels, C. elegans, Polysaccharides, Peptidoglycan, Behavior, Microbial Signaling, Enteric Nervous System

The human gastrointestinal tract harbors trillions of microorganisms, collectively forming a microbiome whose complexity rivals that of any other ecosystem on Earth. While prior research has established the gut microbiome’s role in nutrient absorption and immune modulation, the precise molecular mediators through which gut bacteria communicate with host metabolism have remained elusive. This new research focuses on polypeptides—short chains of amino acids synthesized by gut bacteria—as critical signaling factors that can regulate host metabolic pathways. The identification and characterization of these bacterial polypeptides represent a paradigm shift, suggesting bacteria-derived peptides act similarly to hormones or cytokines within mammalian systems.

By employing shotgun metagenomic sequencing and mass spectrometry-based proteomics, the investigative team catalogued a suite of bacterially produced polypeptides prevalent in healthy human gut microbiomes. These molecules were then isolated and chemically synthesized for controlled experimentation. Among those identified, several polypeptides exhibited remarkable stability through the harsh digestive environment, allowing them to interact with intestinal epithelial cells and systemic circulation. Their biochemical profiles indicate a propensity to modulate key signaling cascades associated with glucose and lipid metabolism, including AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma (PPARγ).

The experimental component utilized rodent models to assess the physiological impact of these bacterial polypeptides. Rodents administered specific peptides through oral gavage demonstrated improved glucose tolerance and insulin sensitivity compared to control groups. In-depth metabolic analyses revealed enhanced mitochondrial function and increased energy expenditure, coupled with significant reductions in adiposity. Tissue biopsies from treated animals indicated upregulated expression of metabolic genes, suggesting direct molecular interaction between administered polypeptides and host cells. Importantly, these effects occurred without altering the composition of the gut microbiota, implicating polypeptides as standalone bioactive effectors.

Mechanistically, the study elucidates that certain polypeptides bind to G-protein coupled receptors (GPCRs) expressed on gut epithelial and enteroendocrine cells, triggering the secretion of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY)—hormones known to regulate appetite and insulin secretion. This crosstalk exemplifies a sophisticated interkingdom communication network, whereby microbial peptides serve as molecular messengers that fine-tune host metabolic responses. Such findings underscore the potential of microbial-derived peptides as novel biotherapeutics capable of mimicking or enhancing endogenous hormone action.

The implications of this research extend into clinical domains, particularly for metabolic syndrome, type 2 diabetes, and obesity—conditions characterized by impaired insulin signaling and disrupted energy homeostasis. The therapeutic utilization of gut bacterial polypeptides offers a potentially safer and more physiologically integrated intervention compared to conventional pharmacotherapies that often have systemic side effects. Furthermore, leveraging naturally occurring bacterial products circumvents some challenges associated with synthetic drug development, presenting a biologically harmonious strategy.

This new understanding also prompts a reevaluation of diet and microbiome modulation in disease management. Since these peptides originate from prevalent bacterial species in the human gut, dietary factors influencing bacterial populations and activity could indirectly regulate peptide production and thus metabolic health. The study’s comprehensive approach included germ-free and antibiotic-treated rodent models, confirming that the absence or disruption of gut bacteria diminished endogenous peptide levels and metabolic benefits. This points to the necessity of preserving microbiome integrity for optimal metabolic functioning.

At a molecular level, polypeptide biosynthesis by gut microbes involves nonribosomal peptide synthetases and ribosomal pathways with post-translational modifications, leading to structurally diverse peptides with distinct functional capabilities. The researchers leveraged gene expression profiling and mutational analyses to identify key bacterial genes responsible for peptide synthesis, setting the stage for future microbial engineering endeavors. By manipulating gene clusters, it may become feasible to enhance production of beneficial peptides within the human gut, tailoring microbiome outputs for personalized metabolic health.

Moreover, this study highlights the versatility of bacterial polypeptides as modulators beyond metabolism, hinting at potential roles in immune regulation, gut barrier integrity, and even neurological functions via the gut-brain axis. The multifaceted nature of these peptides underscores their evolutionary importance as molecular mediators of host-microbe symbiosis. Continued exploration into their structural diversity and receptor selectivity could uncover additional therapeutic targets and diagnostic biomarkers.

The translational potential of these findings is further emphasized by the absence of significant adverse effects in animal models, suggesting a promising safety profile for future peptide-based interventions. Ongoing research is aimed at clinical trials to evaluate efficacy and tolerability in humans, as well as optimization of peptide stability, bioavailability, and targeted delivery systems. If successful, such therapies could complement existing metabolic disorder treatments, offering combination approaches with diet, lifestyle, and pharmacological agents.

In summary, this pioneering research delineates a novel axis of gut microbiome-host metabolic interaction mediated by bacterial polypeptides. The insights gleaned represent a leap forward in microbiome science, underscoring the intricate biochemical dialogues orchestrated by our microbial partners. By unraveling these molecular conversations, scientists pave the way for innovative strategies to harness the microbiome’s metabolic potential, ultimately contributing to healthier lives and combating the global burden of metabolic diseases.

Subject of Research: Investigation of polypeptides synthesized by common gut bacteria and their impact on metabolism in rodent models.

Article Title: Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism.

Article References:

Fan, Y., Lyu, L., Vazquez-Uribe, R. et al. Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism.
Nat Microbiol (2025). https://doi.org/10.1038/s41564-025-02064-x

Image Credits: AI Generated